Cloned (Comment) | Organism |
---|---|
expressed in Escherichia coli BL21(DE3) Codon+-RIL cells | Plasmodium falciparum |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(2E)-3-pyren-1-yl-1-[4-(1H-triaziren-1-yl)phenyl]prop-2-en-1-one | 45% residual activity at 0.05 mM | Plasmodium falciparum | |
1-(4-bromophenyl)-3-(dibenzo[b,d]furan-3-ylamino)propan-1-one | 47% residual activity at 0.05 mM | Plasmodium falciparum | |
2,4-dichloro-N-(2-[[2-oxo-2-(phenylamino)ethyl]sulfanyl]-1,3-benzothiazol-6-yl)benzamide | 49% residual activity at 0.05 mM | Plasmodium falciparum | |
2-[(6-ethoxy-1,3-benzothiazol-2-yl)sulfanyl]-N-(4-methylphenyl)acetamide | 25% residual activity at 0.05 mM | Plasmodium falciparum | |
2-[[4-amino-5-(3,4-dichlorophenyl)-4H-1,2,4-triazol-3-yl]sulfanyl]-N-naphthalen-2-ylacetamide | 3% residual activity at 0.05 mM | Plasmodium falciparum | |
2-[[4-amino-5-(4-chlorophenyl)-4H-1,2,4-triazol-3-yl]sulfanyl]-N-[4-bromo-2-(1-methylethyl)phenyl]acetamide | 52% residual activity at 0.05 mM | Plasmodium falciparum | |
2-[[6-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-1,3-benzothiazol-2-yl]sulfanyl]-N-(4-fluorophenyl)acetamide | 20% residual activity at 0.05 mM | Plasmodium falciparum | |
3-[(4-methylcyclohexyl)sulfamoyl]-N-(4-methylphenyl)benzamide | 49% residual activity at 0.05 mM | Plasmodium falciparum | |
3-[2-(3-fluoro-4-methoxyphenyl)-2-oxoethoxy]-6H-benzo[c]chromen-6-one | 9% residual activity at 0.05 mM | Plasmodium falciparum | |
3-[2-(4-bromophenyl)-2-oxoethoxy]-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one | 53% residual activity at 0.05 mM | Plasmodium falciparum | |
4-bromo-N-(4-chlorophenyl)-3-(phenylsulfamoyl)benzamide | 46% residual activity at 0.05 mM | Plasmodium falciparum | |
4-bromo-N-[2-(3,4-dimethoxyphenyl)-1,3-benzoxazol-5-yl]benzamide | 17% residual activity at 0.05 mM | Plasmodium falciparum | |
4-bromo-N-[4-(trifluoromethyl)phenyl]benzamide | 49% residual activity at 0.05 mM | Plasmodium falciparum | |
N'-[(1E)-(5-bromo-2-hydroxyphenyl)methylidene]-4-(piperidin-1-ylsulfonyl)benzohydrazide | 49% residual activity at 0.05 mM | Plasmodium falciparum | |
N'-[(1Z)-(5-chloro-2-hydroxyphenyl)methylidene]-4-(piperidin-1-ylsulfonyl)benzohydrazide | 24% residual activity at 0.05 mM | Plasmodium falciparum | |
N-(4-bromophenyl)-2-chloro-5-[(4-methylphenyl)sulfamoyl]benzamide | 41% residual activity at 0.05 mM | Plasmodium falciparum | |
triclosan | 0.2% residual activity at 0.05 mM | Plasmodium falciparum |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Plasmodium falciparum | - |
- |
- |
Purification (Comment) | Organism |
---|---|
Ni-NTA affinity column chromatography | Plasmodium falciparum |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
crotonoyl-CoA + NADH | - |
Plasmodium falciparum | butyryl-CoA + NAD+ | - |
? |
Synonyms | Comment | Organism |
---|---|---|
enoyl-ACP reductase | - |
Plasmodium falciparum |
ENR | - |
Plasmodium falciparum |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADH | - |
Plasmodium falciparum |